語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
FindBook
Google Book
Amazon
博客來
Interfering with Interferons : = Interplay Between SARS-CoV-2 and Interferon Response.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Interfering with Interferons :/
其他題名:
Interplay Between SARS-CoV-2 and Interferon Response.
作者:
Chen, Xi.
面頁冊數:
1 online resource (45 pages)
附註:
Source: Dissertations Abstracts International, Volume: 84-11, Section: B.
Contained By:
Dissertations Abstracts International84-11B.
標題:
Tumor necrosis factor-TNF. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30450261click for full text (PQDT)
ISBN:
9798379476700
Interfering with Interferons : = Interplay Between SARS-CoV-2 and Interferon Response.
Chen, Xi.
Interfering with Interferons :
Interplay Between SARS-CoV-2 and Interferon Response. - 1 online resource (45 pages)
Source: Dissertations Abstracts International, Volume: 84-11, Section: B.
Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2023.
Includes bibliographical references
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirusdisease 2019 (COVID-19) pandemic, which has been an ongoing global health crisis. At thebeginning of the pandemic, all the efforts were directed toward understanding the pathogenesisof the virus. An early interferon (IFN) response is crucial in initiating and boosting the antiviralresponse. It was identified that the IFN response is dim and delayed in COVID-19 patients,accompanied by pro-inflammatory cytokine production. Circumvention and dysregulation ofinterferon (IFN) response were found to be characteristic of the SARS-CoV-2 infection,leading to its pathogenicity and severity in a group of COVID-19 patients. Thus, a betterunderstanding of the pathogenic mechanisms of SARS-CoV-2 infection is crucial for a bettertherapeutic strategy against the disease. The thesis aimed to characterize the interplay betweenSARS-CoV-2 and host IFN response.In Paper I, we assessed the susceptibility and cytotoxicity of the first Swedish isolate of SARSCoV-2 in six cell lines of human origin in comparison to other globally isolated strains.Furthermore, we determined the proteomic landscape during SARS-CoV-2 infection in thesusceptible cell lines, using LC-MS/MS-based tandem mass tags (TMT) labeling quantitativeproteomics technology. The studies provided an overview of the signaling pathways altered bythe SARS-CoV-2, elucidating IFN-signaling pathways.In Paper II, we identified and characterized the expression of antiviral ISGs during SARSCoV-1, MERS-CoV, and SARS-CoV-2 infection of the Huh7 cell line using TMT-labeled LCMS/MS. Transcriptomic ISG signatures were identified for SARS-CoV-2 in a time-dependentmanner. Furthermore, we identified that SARS-CoV-2 inhibited IFN-b production and showeda muted and delayed activation of ISGs in Huh7 cells. IFN treatment was found to be effectivein controlling the virus prior to the establishment of the infection, and IFN treatment postinfectionhad no effect on the virus. We also showed increased virus production in a senescentHuh cell model.Paper III explored how the virus infection impacts the IFN signaling pathways (IFN-I/ IFNIII)and interferon-stimulated gene (ISG) expression in COVID-19 patients. Irrespective of thedisease status, heterogeneity was observed in the expression of ISGs. We categorized thepatients based on type-I, type-II, and antiviral-response-related ISG scores obtained fromwhole-blood transcriptomics data. We investigated factors like immune cell proportions,neutrophil extracellular traps (NETs), inflammatory factors, metabolic status, andautoimmunity against IFNs, to try to find any association with the ISG score status of thepatients. Autoimmune antibodies against IFNs were more prominent in patients with low ISGscores. Furthermore, the expression of ISGs was associated with a perturbation in amino acidand lipid metabolism.In Paper IV, we investigated a potential innate immune evasion mechanism by SARS-CoV-2. We studied the role of a crucial virus protease: papain-like protease (PLpro), which has apotent deubiquitinating and deISGylating activity in inhibiting type-I IFN response. Usingimmunoprecipitation, we have identified that SARS-CoV-2 interacts with RIG-I signalosomecomponents TRIM25 and RIG-I. Catalytically active PLpro could deubiquitinate theconstitutively active 2CARD domain, which leads to the inhibition of interferon response. TheSARS-CoV-2 homologs in other coronaviruses also interacted with TRIM25 and RIG-I andinhibited IFN production. These findings show another innate immune regulatory mechanismby Ub/UbL deconjugated activity of coronavirus PLpro.In summary, the research covered in this thesis deciphers the significance of interferon responseduring SARS-CoV-2 infection.
Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023
Mode of access: World Wide Web
ISBN: 9798379476700Subjects--Topical Terms:
3560383
Tumor necrosis factor-TNF.
Index Terms--Genre/Form:
542853
Electronic books.
Interfering with Interferons : = Interplay Between SARS-CoV-2 and Interferon Response.
LDR
:05055nmm a2200337K 4500
001
2365782
005
20231218204708.5
006
m o d
007
cr mn ---uuuuu
008
241011s2023 xx obm 000 0 eng d
020
$a
9798379476700
035
$a
(MiAaPQ)AAI30450261
035
$a
(MiAaPQ)Karolinska_1061648488
035
$a
AAI30450261
040
$a
MiAaPQ
$b
eng
$c
MiAaPQ
$d
NTU
100
1
$a
Chen, Xi.
$3
1017731
245
1 0
$a
Interfering with Interferons :
$b
Interplay Between SARS-CoV-2 and Interferon Response.
264
0
$c
2023
300
$a
1 online resource (45 pages)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
500
$a
Source: Dissertations Abstracts International, Volume: 84-11, Section: B.
500
$a
Advisor: Gupta, Soham;Neogi, Ujjwal;Vegvari, Akos.
502
$a
Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2023.
504
$a
Includes bibliographical references
520
$a
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirusdisease 2019 (COVID-19) pandemic, which has been an ongoing global health crisis. At thebeginning of the pandemic, all the efforts were directed toward understanding the pathogenesisof the virus. An early interferon (IFN) response is crucial in initiating and boosting the antiviralresponse. It was identified that the IFN response is dim and delayed in COVID-19 patients,accompanied by pro-inflammatory cytokine production. Circumvention and dysregulation ofinterferon (IFN) response were found to be characteristic of the SARS-CoV-2 infection,leading to its pathogenicity and severity in a group of COVID-19 patients. Thus, a betterunderstanding of the pathogenic mechanisms of SARS-CoV-2 infection is crucial for a bettertherapeutic strategy against the disease. The thesis aimed to characterize the interplay betweenSARS-CoV-2 and host IFN response.In Paper I, we assessed the susceptibility and cytotoxicity of the first Swedish isolate of SARSCoV-2 in six cell lines of human origin in comparison to other globally isolated strains.Furthermore, we determined the proteomic landscape during SARS-CoV-2 infection in thesusceptible cell lines, using LC-MS/MS-based tandem mass tags (TMT) labeling quantitativeproteomics technology. The studies provided an overview of the signaling pathways altered bythe SARS-CoV-2, elucidating IFN-signaling pathways.In Paper II, we identified and characterized the expression of antiviral ISGs during SARSCoV-1, MERS-CoV, and SARS-CoV-2 infection of the Huh7 cell line using TMT-labeled LCMS/MS. Transcriptomic ISG signatures were identified for SARS-CoV-2 in a time-dependentmanner. Furthermore, we identified that SARS-CoV-2 inhibited IFN-b production and showeda muted and delayed activation of ISGs in Huh7 cells. IFN treatment was found to be effectivein controlling the virus prior to the establishment of the infection, and IFN treatment postinfectionhad no effect on the virus. We also showed increased virus production in a senescentHuh cell model.Paper III explored how the virus infection impacts the IFN signaling pathways (IFN-I/ IFNIII)and interferon-stimulated gene (ISG) expression in COVID-19 patients. Irrespective of thedisease status, heterogeneity was observed in the expression of ISGs. We categorized thepatients based on type-I, type-II, and antiviral-response-related ISG scores obtained fromwhole-blood transcriptomics data. We investigated factors like immune cell proportions,neutrophil extracellular traps (NETs), inflammatory factors, metabolic status, andautoimmunity against IFNs, to try to find any association with the ISG score status of thepatients. Autoimmune antibodies against IFNs were more prominent in patients with low ISGscores. Furthermore, the expression of ISGs was associated with a perturbation in amino acidand lipid metabolism.In Paper IV, we investigated a potential innate immune evasion mechanism by SARS-CoV-2. We studied the role of a crucial virus protease: papain-like protease (PLpro), which has apotent deubiquitinating and deISGylating activity in inhibiting type-I IFN response. Usingimmunoprecipitation, we have identified that SARS-CoV-2 interacts with RIG-I signalosomecomponents TRIM25 and RIG-I. Catalytically active PLpro could deubiquitinate theconstitutively active 2CARD domain, which leads to the inhibition of interferon response. TheSARS-CoV-2 homologs in other coronaviruses also interacted with TRIM25 and RIG-I andinhibited IFN production. These findings show another innate immune regulatory mechanismby Ub/UbL deconjugated activity of coronavirus PLpro.In summary, the research covered in this thesis deciphers the significance of interferon responseduring SARS-CoV-2 infection.
533
$a
Electronic reproduction.
$b
Ann Arbor, Mich. :
$c
ProQuest,
$d
2023
538
$a
Mode of access: World Wide Web
650
4
$a
Tumor necrosis factor-TNF.
$3
3560383
650
4
$a
Viruses.
$3
571474
650
4
$a
Middle East respiratory syndrome.
$3
3688584
650
4
$a
Respiratory diseases.
$3
3689770
650
4
$a
Coronaviruses.
$3
894828
650
4
$a
Medical research.
$2
bicssc
$3
1556686
650
4
$a
COVID-19.
$3
3554449
650
4
$a
Medicine.
$3
641104
650
4
$a
Virology.
$3
642304
655
7
$a
Electronic books.
$2
lcsh
$3
542853
690
$a
0564
690
$a
0720
710
2
$a
ProQuest Information and Learning Co.
$3
783688
710
2
$a
Karolinska Institutet (Sweden).
$3
3557748
773
0
$t
Dissertations Abstracts International
$g
84-11B.
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30450261
$z
click for full text (PQDT)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9488138
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入